ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,515Medicare Part D Prescriptions Filled, Including Refills

Rank: 98 out of 252

$493K Total Retail Price of All Prescriptions

Rank: 101 out of 252

466 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 466 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 466 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 8,808 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 396 380 1 2
LEVOTHYROXINE SODIUM 346 319 2 1
ZOLPIDEM TARTRATE 287 250 3 21
FUROSEMIDE 263 254 4 7
AMLODIPINE BESYLATE 261 246 5 4
OMEPRAZOLE 210 199 6 6
LISINOPRIL 210 200 6 3
PRAVASTATIN SODIUM 204 204 8 12
ATENOLOL 199 194 9 18
ATORVASTATIN CALCIUM 188 170 10 16
METOPROLOL SUCCINATE 183 177 11 19
POTASSIUM CHLORIDE 175 165 12 8
HYDROCODONE-ACETAMINOPHEN 167 129 S3 13 5
LOSARTAN POTASSIUM 142 139 14 24
TRAMADOL HCL 129 122 15 17
CITALOPRAM HBR 127 121 16 15
TRIAMTERENE-HCTZ 127 124 16 33
MELOXICAM 124 120 18 20
ALENDRONATE SODIUM 124 124 18 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 116 101 20 25
METOPROLOL TARTRATE 102 99 21 10
GABAPENTIN 101 97 22 11
FLUTICASONE PROPIONATE 97 95 23 36
WARFARIN SODIUM 94 84 24 14
NEXIUM 91 80 25 23
TAMSULOSIN HCL 91 67 25 26
HYDROCHLOROTHIAZIDE 88 84 27 13
CIPROFLOXACIN HCL 86 77 28 61
AMLODIPINE BESYLATE-BENAZEPRIL 86 73 28 60
DIOVAN 84 84 30 38
CYMBALTA 80 64 31 45
CLONIDINE HCL 80 80 31 35
CLOPIDOGREL 79 69 33 29
ALLOPURINOL 79 79 33 30
AZITHROMYCIN 79 69 33 37
METFORMIN HCL ER 77 65 36 74
SERTRALINE HCL 76 52 37 27
FLUOXETINE HCL 75 68 38 57
PLAVIX 71 61 39 43
AMITRIPTYLINE HCL 67 61 R 40 46
DONEPEZIL HCL 67 67 40 28
ESTRADIOL 64 64 R 42 76
PAROXETINE HCL 61 61 43 75
CARVEDILOL 61 61 43 22
TRAZODONE HCL 57 57 45 31
PREMARIN 56 51 R 46 116
RAMIPRIL 55 55 47 71
LOSARTAN-HYDROCHLOROTHIAZIDE 53 53 48 49
GLIMEPIRIDE 53 41 48 40
BENICAR 50 50 50 143
GLYBURIDE-METFORMIN HCL 50 44 R 50 82
CELEBREX 50 50 50 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.